Top 10 Medical Stocks To Buy Right Now

tags:LEXEA,IPHI,ACBI,PRI,IMMY,HTS,ICD,VKI,BDSI,TWER, If you find yourself with $1,000 all of a sudden -- or perhaps through slow consistent saving -- you might be wondering: What's next? Maybe ideas of a beach vacation are floating through your head, or maybe you're thinking about buying yourself a big-ticket gadget like a new computer or TV.

You can certainly spend your money on those things if you want, but here are 10 smart things you could do with that $1,000 right now to improve your financial well-being.

 

More:Do I need a nest egg if I never plan to retire? Quick answer is absolutely!

1. Pay off your debts

If you're carrying any high-interest debt like a balance on your credit card, medical bills, or a personal line of credit, you should absolutely be paying it off as quickly as possible. $1,000 can go a long way toward clearing your debt, especially if you're only making minimum monthly payments.

Top 10 Medical Stocks To Buy Right Now: Liberty Expedia Holdings, Inc. (LEXEA)

Advisors' Opinion:

• [By Joseph Griffin]

  Tyers Asset Management LLC reduced its holdings in shares of Liberty Expedia Holdings Inc Series A (NASDAQ:LEXEA) by 54.9% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 3,192 shares of the technology company’s stock after selling 3,892 shares during the quarter. Tyers Asset Management LLC’s holdings in Liberty Expedia Holdings Inc Series A were worth $140,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Top 10 Medical Stocks To Buy Right Now: Inphi Corporation(IPHI)

Advisors' Opinion:

• [By Ezra Schwarzbaum]

  Several other optics stocks stand to gain. In a Monday note, Bank of America Merrill Lynch analyst Vivek Arya also highlighlited the semiconductor space as one that could benefit from the news. Other stocks to watch include:

  Lumentum Holdings Inc (NASDAQ: LITE) Ciena Corporation (NYSE: CIEN) Coherent, Inc. (NASDAQ: COHR) II-VI, Inc. (NASDAQ: IIVI) Inphi Corporation (NYSE: IPHI) Skyworks Solutions Inc (NASDAQ: SWKS) Integrated Device Technology Inc (NASDAQ: IDTI) Qorvo Inc (NASDAQ: QRVO) Xilinx, Inc. (NASDAQ: XLNX) Broadcom Inc (NASDAQ: AVGO)

  Related Links:

• [By Max Byerly]

  Get a free copy of the Zacks research report on Inphi (IPHI)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By ]

  There are some companies that have weak fundamentals and are regularly incurring losses but that are valued strongly by the market purely based on one metric: revenue growth. Inphi Corporation (NYSE:IPHI) is the perfect example of such a company that has enjoyed a very high valuation despite being a loss-making unit for a large period within the past five years. The company's revenue growth was phenomenal and the profits were expected soon. In fact, the company did end up with a good profit in 2016 when the EV/Sales multiple shot up above 7.

Top 10 Medical Stocks To Buy Right Now: Atlantic Capital Bancshares, Inc.(ACBI)

Advisors' Opinion:

• [By Motley Fool Transcribers]

  Atlantic Capital Bancshares, Inc.  (NASDAQ:ACBI)Q4 2018 Earnings Conference CallFeb. 01, 2019, 10:00 a.m. ET

  Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:

  Operator

• [By Shane Hupp]

  Media stories about Atlantic Capital (NASDAQ:ACBI) have trended somewhat positive this week, Accern Sentiment reports. The research firm identifies negative and positive news coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Atlantic Capital earned a coverage optimism score of 0.09 on Accern’s scale. Accern also assigned media stories about the bank an impact score of 47.7189806803557 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.

• [By Max Byerly]

  Get a free copy of the Zacks research report on Atlantic Capital (ACBI)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Max Byerly]

  Shares of Atlantic Capital Bancshares Inc (NASDAQ:ACBI) have been given a consensus recommendation of “Hold” by the eight brokerages that are covering the stock, MarketBeat reports. Two equities research analysts have rated the stock with a sell rating, four have given a hold rating and one has given a buy rating to the company. The average 1 year price target among brokerages that have issued ratings on the stock in the last year is $18.50.

Top 10 Medical Stocks To Buy Right Now: Primerica, Inc.(PRI)

Advisors' Opinion:

• [By Stephan Byrd]

  Wells Fargo & Company MN boosted its stake in Primerica (NYSE:PRI) by 2.3% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 838,510 shares of the financial services provider’s stock after purchasing an additional 19,142 shares during the quarter. Wells Fargo & Company MN’s holdings in Primerica were worth $81,000,000 as of its most recent SEC filing.

• [By Motley Fool Transcribers]

  Primerica Inc  (NYSE:PRI)Q4 2018 Earnings Conference CallFeb. 08, 2019, 10:00 a.m. ET

  Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:

  Operator

• [By Joseph Griffin]

  Primerica (NYSE:PRI) has been assigned a consensus recommendation of “Hold” from the six brokerages that are currently covering the firm, MarketBeat.com reports. Six equities research analysts have rated the stock with a hold rating. The average 1-year target price among brokers that have issued a report on the stock in the last year is $103.00.

• [By Lisa Levin]

   

  Companies Reporting After The Bell Marriott International, Inc. (NASDAQ: MAR) is projected to post quarterly earnings at $1.22 per share on revenue of $5.72 billion. Electronic Arts Inc. (NASDAQ: EA) is estimated to post quarterly earnings at $1.04 per share on revenue of $5.68 billion. The Walt Disney Company (NYSE: DIS) is projected to post quarterly earnings at $1.68 per share on revenue of $14.05 billion. Papa John's International, Inc. (NASDAQ: PZZA) is expected to post quarterly earnings at $0.62 per share on revenue of $441.73 million. Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is projected to post quarterly earnings at $2.77 per share on revenue of $434.87 million. Sun Life Financial Inc. (NYSE: SLF) is estimated to post quarterly earnings at $0.89 per share on revenue of $6.38 billion. LATAM Airlines Group S.A. (NYSE: LTM) is expected to post quarterly earnings at $0.16 per share on revenue of $2.70 billion. Liberty Global plc (NASDAQ: LBTYA) is projected to post quarterly earnings at $0.02 per share on revenue of $4.05 billion. TripAdvisor, Inc. (NASDAQ: TRIP) is expected to post quarterly earnings at $0.16 per share on revenue of $362.11 million. The Wendy's Company (NASDAQ: WEN) is projected to post quarterly earnings at $0.1 per share on revenue of $379.98 million. A-Mark Precious Metals, Inc. (NASDAQ: AMRK) is expected to post quarterly earnings at $0.06 per share on revenue of $1.69 billion. Monster Beverage Corporation (NASDAQ: MNST) is estimated to post quarterly earnings at $0.4 per share on revenue of $849.38 million. Convergys Corporation (NYSE: CVG) is expected to post quarterly earnings at $0.4 per share on revenue of $670.10 million. ScanSource, Inc. (NASDAQ: SCSC) is projected to post quarterly earnings at $0.7 per share on revenue of $875.91 million. KAR Auction Services, Inc. (NYSE: KAR) is expected to post quarterly earnings at $0.76 per share on revenue of $923.13

Top 10 Medical Stocks To Buy Right Now: Imprimis Pharmaceuticals, Inc.(IMMY)

Advisors' Opinion:

• [By Stephan Byrd]

  Headlines about Imprimis Pharmaceuticals (NASDAQ:IMMY) have been trending positive recently, according to Accern Sentiment Analysis. Accern identifies negative and positive press coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Imprimis Pharmaceuticals earned a daily sentiment score of 0.25 on Accern’s scale. Accern also gave media headlines about the specialty pharmaceutical company an impact score of 47.393314841388 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.

• [By Lisa Levin] Gainers Blink Charging Co. (NASDAQ: BLNK) shares jumped 26.5 percent to $6.9042. Blink Charging reported Q1 net income of $2.2 million, versus a year-ago net loss of $3.1 million. Eleven Biotherapeutics, Inc. (NASDAQ: EBIO) shares climbed 17.4 percent to $3.11. Eleven Biotherapeutics posted a Q1 loss of $0.11 per share. Flanigan's Enterprises, Inc. (NYSE: BDL) shares jumped 17 percent to $27.97 following Q2 results. Flanigan's Enterprises posted Q2 earnings of $0.75 per share on sales of $29.456 million. Borqs Technologies, Inc. (NASDAQ: BRQS) rose 15.8 percent to $8.05 after reporting Q1 results. Abaxis, Inc. (NASDAQ: ABAX) jumped 15.3 percent to $82.75. Zoetis Inc. (NYSE: ZTS) announced plans to acquire Abaxis for $83 per share in cash. 21Vianet Group, Inc. (NASDAQ: VNET) gained 15.1 percent to $6.33. Gemphire Therapeutics Inc. (NASDAQ: GEMP) rose 13.8 percent to $6.27. Enphase Energy, Inc. (NASDAQ: ENPH) gained 12.8 percent to $5.98. H.C. Wainwright initiated coverage on Enphase Energy with a Buy rating. PetIQ Inc (NASDAQ: PETQ) shares surged 12.1 percent to $21.68 after reporting a first-quarter sales beat. NF Energy Saving Corporation (NASDAQ: NFEC) climbed 11.6 percent to $2.399. Allied Healthcare Products, Inc. (NASDAQ: AHPI) surged 11.4 percent to $3.0643. Boot Barn Holdings, Inc. (NYSE: BOOT) gained 11.1 percent to $24.40 after the company reported upbeat results for its fourth quarter and issued strong first-quarter earnings guidance. Ascena Retail Group, Inc. (NASDAQ: ASNA) rose 10.9 percent to $3.16. Sea Limited (NYSE: SE) gained 10.1 percent to $11.71 after reporting Q1 results. GEE Group, Inc. (NYSE: JOB) climbed 7.9 percent to $2.61 following Q2 results. The ONE Group Hospitality, Inc. (NASDAQ: STKS) gained 7.6 percent to $2.41 after reporting Q1 results. Biolinerx Ltd/S ADR (NASDAQ: BLRX) rose 7.3 percent to $0.8798 after the company was granted a patent approval. The clinical-st
• [By Lisa Levin] Gainers Boot Barn Holdings, Inc. (NYSE: BOOT) rose 15.6 percent to $25.40 in pre-market trading after the company reported upbeat results for its fourth quarter and issued strong first-quarter earnings guidance. Abaxis, Inc. (NASDAQ: ABAX) rose 15.3 percent to $82.75 in pre-market trading. Zoetis Inc. (NYSE: ZTS) announced plans to acquire Abaxis for $83 per share in cash. Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) rose 12.6 percent to $8.95 in pre-market trading after reporting Q1 results. Micro Focus International plc (NYSE: MFGP) shares rose 8.8 percent to $18.59 in the pre-market trading session after the company issued strong revenue forecast for the first fiscal half of 2018. HC2 Holdings, Inc. (NASDAQ: HCHC) rose 5.6 percent to $6.60 in pre-market trading. Eleven Biotherapeutics, Inc. (NASDAQ: EBIO) shares rose 5.3 percent to $2.79 in pre-market trading. Eleven Biotherapeutics posted a Q1 loss of $0.11 per share. Imprimis Pharmaceuticals Inc (NASDAQ: IMMY) rose 5.2 percent to $2.52 in pre-market trading after reporting a first-quarter sales beat. Red Violet, Inc. (NASDAQ: RDVT) rose 4.1 percent to $10.35 in pre-market trading after climbing 75.31 percent on Tuesday. Xenon Pharmaceuticals Inc (NASDAQ: XENE) rose 3.8 percent to $6.90 in pre-market trading. The stock rose over 10 percent Tuesday after reporting its Phase 1 clinical update on XEN901 demonstrated a favorable PK profile. Sea Limited (NYSE: SE) rose 3.5 percent to $11.01 in pre-market trading after reporting Q1 results. Teva Pharmaceutical Industries Limited (NYSE: TEVA) shares rose 3.4 percent to $20.98 in pre-market trading after Buffett's Berkshire more than doubled its stake in Teva. China Internet Nationwide Financial Services Inc. (NASDAQ: CIFS) shares rose 3.7 percent to $31.30 in pre-market trading after the company reported results for its fourth quarter. PetIQ Inc (NASDAQ: PETQ) shares rose 3.4 percent to $20.00 in pre-market t

Top 10 Medical Stocks To Buy Right Now: Hatteras Financial Corp(HTS)

Advisors' Opinion:

• [By Joseph Griffin]

  Media headlines about Hatteras Financial (NYSE:HTS) have trended positive on Wednesday, according to Accern Sentiment. Accern rates the sentiment of news coverage by reviewing more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Hatteras Financial earned a news sentiment score of 0.26 on Accern’s scale. Accern also gave headlines about the real estate investment trust an impact score of 45.8883073191268 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.

• [By Ethan Ryder]

  News articles about Hatteras Financial (NYSE:HTS) have trended positive on Sunday, Accern reports. The research firm identifies positive and negative media coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Hatteras Financial earned a media sentiment score of 0.31 on Accern’s scale. Accern also gave news headlines about the real estate investment trust an impact score of 46.6332645118122 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

Top 10 Medical Stocks To Buy Right Now: Independence Contract Drilling, Inc.(ICD)

Advisors' Opinion:

• [By WWW.GURUFOCUS.COM]

  For the details of AXAR CAPITAL MANAGEMENT L.P.'s stock buys and sells, go to https://www.gurufocus.com/guru/axar+capital+management+l.p./current-portfolio/portfolio

  These are the top 5 holdings of AXAR CAPITAL MANAGEMENT L.P.SPDR S&P 500 (SPY) - 1,220,000 shares, 91.31% of the total portfolio. Stonemor Partners LP (STON) - 7,384,970 shares, 4.64% of the total portfolio. Shares added by 7.35%Patterson-UTI Energy Inc (PTEN) - 730,000 shares, 2.26% of the total portfolio. Independence Contract Drilling Inc (ICD) - 969,662 shares, 0.91% of the total portfolio. New PositionStage Stores Inc (SSI) - 3,700,000 shares, 0.82% of the total portfolio. Shares added by 6
• [By Ethan Ryder]

  Get a free copy of the Zacks research report on Independence Contract Drilling (ICD)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By WWW.GURUFOCUS.COM]

  For the details of AXAR CAPITAL MANAGEMENT L.P.'s stock buys and sells, go to https://www.gurufocus.com/guru/axar+capital+management+l.p./current-portfolio/portfolio

  These are the top 5 holdings of AXAR CAPITAL MANAGEMENT L.P.SPDR S&P 500 (SPY) - 1,220,000 shares, 91.31% of the total portfolio. Stonemor Partners LP (STON) - 7,384,970 shares, 4.64% of the total portfolio. Shares added by 7.35%Patterson-UTI Energy Inc (PTEN) - 730,000 shares, 2.26% of the total portfolio. Independence Contract Drilling Inc (ICD) - 969,662 shares, 0.91% of the total portfolio. New PositionStage Stores Inc (SSI) - 3,700,000 shares, 0.82% of the total portfolio. Shares added by 6
• [By Ethan Ryder]

  Independence Contract (NYSE: ICD) and Pacific Drilling (OTCMKTS:PACDQ) are both small-cap oils/energy companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, institutional ownership, analyst recommendations, risk, valuation, dividends and profitability.

• [By Motley Fool Transcribers]

  Independence Contract Drilling Inc  (NYSE:ICD)Q4 2018 Earnings Conference CallMarch 01, 2019, 10:00 a.m. ET

  Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:

  Operator

Top 10 Medical Stocks To Buy Right Now: Invesco Advantage Municipal Income Trust II(VKI)

Advisors' Opinion:

• [By Stephan Byrd]

  Invesco Advantage Municipal Income Tr II (NYSEAMERICAN:VKI) declared a monthly dividend on Thursday, August 2nd, Wall Street Journal reports. Investors of record on Tuesday, August 14th will be given a dividend of 0.0517 per share by the financial services provider on Friday, August 31st. This represents a $0.62 annualized dividend and a yield of 5.77%. The ex-dividend date is Monday, August 13th.

• [By Ethan Ryder]

  Wedbush Securities Inc. bought a new stake in Invesco Advantage Municipal Income Trust II (NYSEAMERICAN:VKI) during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 35,963 shares of the financial services provider’s stock, valued at approximately $382,000. Wedbush Securities Inc. owned 0.08% of Invesco Advantage Municipal Income Trust II as of its most recent SEC filing.

• [By Stephan Byrd]

  Invesco Advantage Municipal Income Tr II (NYSEAMERICAN:VKI) declared a monthly dividend on Tuesday, October 2nd, Wall Street Journal reports. Stockholders of record on Tuesday, October 16th will be given a dividend of 0.0493 per share by the financial services provider on Wednesday, October 31st. This represents a $0.59 annualized dividend and a dividend yield of 5.65%. The ex-dividend date of this dividend is Monday, October 15th.

Top 10 Medical Stocks To Buy Right Now: BioDelivery Sciences International Inc.(BDSI)

Advisors' Opinion:

• [By Joseph Griffin]

  BioDelivery Sciences International, Inc. (NASDAQ:BDSI) Director Francis E. Odonnell, Jr. sold 8,000 shares of the firm’s stock in a transaction on Friday, February 1st. The stock was sold at an average price of $4.60, for a total value of $36,800.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.

• [By Logan Wallace]

  BioDelivery Sciences International (NASDAQ:BDSI) had its target price reduced by research analysts at HC Wainwright from $4.00 to $3.50 in a research report issued to clients and investors on Wednesday. The brokerage currently has a “buy” rating on the specialty pharmaceutical company’s stock. HC Wainwright’s price objective points to a potential upside of 40.00% from the company’s current price.

• [By Lisa Levin]

  BioDelivery Sciences International, Inc. (NASDAQ: BDSI) shares were also up, gaining 19 percent to $2.3272 after the company announced board restructuring plan and $50m equity financing deal led by Broadfin to "significantly strengthen" financial position.

Top 10 Medical Stocks To Buy Right Now: Towerstream Corporation(TWER)

Advisors' Opinion:

• [By Max Byerly]

  Magyar Telekom Tavkozlesi Nyrt (OTCMKTS:MYTAY) and Towerstream (OTCMKTS:TWER) are both small-cap utilities companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, earnings, risk, dividends, profitability, institutional ownership and valuation.

• [By Ethan Ryder]

  Global Eagle Entertainment (OTCMKTS: TWER) and Towerstream (OTCMKTS:TWER) are both small-cap computer and technology companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, institutional ownership, valuation, analyst recommendations, risk, earnings and profitability.